BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Total Liabilities : $55.99 Mil (As of Feb. 2024)

View and export this data going back to 2017. Start your Free Trial

What is BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Total Liabilities?

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Total Liabilities for the quarter that ended in Feb. 2024 was $55.99 Mil.

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's quarterly Total Liabilities declined from Feb. 2023 ($63.82 Mil) to Aug. 2023 ($52.97 Mil) but then increased from Aug. 2023 ($52.97 Mil) to Feb. 2024 ($55.99 Mil).

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's annual Total Liabilities declined from Aug. 2021 ($77.56 Mil) to Aug. 2022 ($65.22 Mil) and declined from Aug. 2022 ($65.22 Mil) to Aug. 2023 ($52.97 Mil).

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Total Liabilities Historical Data

The historical data trend for BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Total Liabilities Chart

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Annual Data

Trend

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Total Liabilities

Get a 7-Day Free Trial

63.43

58.49

77.56

65.22

52.97

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Semi-Annual Data
	Feb19	Aug19	Feb20	Aug20	Feb21	Aug21	Feb22	Aug22	Feb23	Aug23	Feb24
Total Liabilities	Get a 7-Day Free Trial						62.21	65.22	63.82	52.97	55.99

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Total Liabilities for the fiscal year that ended in Aug. 2023 is calculated as

Total Liabilities	=	Total Assets (A: Aug. 2023 )	-	Total Equity (A: Aug. 2023 )
	=	176.51	-	123.539
	=	52.97

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Total Liabilities for the quarter that ended in Feb. 2024 is calculated as

Total Liabilities	=	Total Assets (Q: Feb. 2024 )	-	Total Equity (Q: Feb. 2024 )
	=	188.676	-	132.683
	=	55.99

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Total Liabilities Related Terms

Thank you for viewing the detailed overview of BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund Inc (NYSE:DCF) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

c/o BNY Mellon Investment Adviser, Inc., 240 Greenwich Street, New York, NY, USA, 10286

Website

https://www.bnymellonim.com

BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund Inc is a diversified closed-end management investment company. Its investment objectives are to seek high current income and to return at least the Fund's original NAV to holders of record of common shares on or about the termination date.

Executives

Bushra Mannan	other: Director of BNYMIA (1)	C/O BNY MELLON INVESTMENT ADVISER, INC., 240 GREENWICH STREET, NEW YORK NY 10286
Irene Papadoulis	other: Director of BNYMIA (1)	C/O BNY MELLON INVESTMENT ADVISER, INC., 240 GREENWICH STREET, NEW YORK NY 10286
Ping Jiang	other: Dir. of Invest. Oversight (1)	C/O BNY MELLON INVESTMENT ADVISER, INC., 240 GREENWICH STREET, NEW YORK NY 10286
Bradley J Skapyak	officer: President	200 PARK AVENUE, NEW YORK NY 10166
Joseph Martella	officer: VP	C/O BNY MELLON INVESTMENT ADVISER, INC., 240 GREENWICH STREET, NEW YORK NY 10288
Daniel Goldstein	officer: VP	240 GREENWICH STREET, NEW YORK NY 10286
Robert J. Pomeroy	officer: VP; Investment Adviser	C/O BNY MELLON INVESTMENT ADVISER, INC., 240 GREENWICH STREET, NEW YORK NY 10286
Vinay Patel	other: Head of Finance of Sub-Adviser	200 PARK AVE, NEW YORK CITY NY 10166
Alcentra Ny, Llc	other: Sub-Adviser	200 PARK AVENUE, 7TH FLOOR, NEW YORK NY 10166
Brandon Chao	other: Portfolio Mgr of Sub-Adviser	200 PARK AVENUE, NEW YORK CITY NY 10166
Laurence Raven	other: Portfolio Mgr of Sub-Adviser	200 PARK AVENUE, NEW YORK CITY NY 10166
Ross Curran	other: Portfolio Mgr of Sub-Adviser	200 PARK AVENUE, NEW YORK CITY NY 10166
Cathy Bevan	other: Portfolio Mgr of Sub-Adviser	200 PARK AVENUE, NEW YORK CITY NY 10166
Daire Wheeler	other: Portfolio Mgr of Sub-Adviser	200 PARK AVENUE, NEW YORK CITY NY 10166
Eric Larsson	other: Portfolio Mgr of Sub-Adviser	C/O ALCENTRA NY LLC, 200 PARK AVENUE, NEW YORK CITY NY 10166